| Dr Edwin Bannacek Lopez, MD | |
|
Calle Francisco G Bruno #48 Oeste Esquina San Antonio, Guayama, PR 00784-0078 | |
| (787) 409-6657 | |
| (787) 409-6657 |
| Full Name | Dr Edwin Bannacek Lopez |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | Calle Francisco G Bruno #48 Oeste Esquina San Antonio, Guayama, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164920807 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 19831 (Puerto Rico) | Primary |
| Entity Name | Hospital Menonita De Cayey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750317764 PECOS PAC ID: 2466449657 Enrollment ID: O20040429000135 |
News Archive
Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. After comprehensive review by Ambry's staff of geneticists and medical directors, these results will allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
A study using mice provides insight into how a specific receptor subtype in the brain could play a role in increasing a person's risk for attention-deficit hyperactivity disorder.
NovoStent® Corporation, a privately held medical device company, today announced that it has received CE Mark for its SAMBATM Stent and Delivery System for the treatment of peripheral artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of strength, flexibility and vessel coverage.
Use the right tool for the job. Today experts outline the best way to identify people most likely to develop common and devastating heart rhythm disorders.
› Verified 5 days ago
| Entity Name | Centro Medico Del Turabo Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710107883 PECOS PAC ID: 9335051952 Enrollment ID: O20080212000105 |
News Archive
Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. After comprehensive review by Ambry's staff of geneticists and medical directors, these results will allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
A study using mice provides insight into how a specific receptor subtype in the brain could play a role in increasing a person's risk for attention-deficit hyperactivity disorder.
NovoStent® Corporation, a privately held medical device company, today announced that it has received CE Mark for its SAMBATM Stent and Delivery System for the treatment of peripheral artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of strength, flexibility and vessel coverage.
Use the right tool for the job. Today experts outline the best way to identify people most likely to develop common and devastating heart rhythm disorders.
› Verified 5 days ago
| Entity Name | Find U Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265038996 PECOS PAC ID: 2769896430 Enrollment ID: O20210121001029 |
News Archive
Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. After comprehensive review by Ambry's staff of geneticists and medical directors, these results will allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
A study using mice provides insight into how a specific receptor subtype in the brain could play a role in increasing a person's risk for attention-deficit hyperactivity disorder.
NovoStent® Corporation, a privately held medical device company, today announced that it has received CE Mark for its SAMBATM Stent and Delivery System for the treatment of peripheral artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of strength, flexibility and vessel coverage.
Use the right tool for the job. Today experts outline the best way to identify people most likely to develop common and devastating heart rhythm disorders.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edwin Bannacek Lopez, MD Po Box 13, Guayama, PR 00785-0013 Ph: (787) 409-6657 | Dr Edwin Bannacek Lopez, MD Calle Francisco G Bruno #48 Oeste Esquina San Antonio, Guayama, PR 00784-0078 Ph: (787) 409-6657 |
News Archive
Ambry Genetics today announces that it is the first laboratory to provide CLIA-approved exome services for applications in clinical diagnostics. After comprehensive review by Ambry's staff of geneticists and medical directors, these results will allow clinicians to diagnose affected patients with conditions that have eluded traditional diagnostic approaches.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
A study using mice provides insight into how a specific receptor subtype in the brain could play a role in increasing a person's risk for attention-deficit hyperactivity disorder.
NovoStent® Corporation, a privately held medical device company, today announced that it has received CE Mark for its SAMBATM Stent and Delivery System for the treatment of peripheral artery disease. The SAMBA Stent was designed to treat the highly varied presentation of atherosclerotic disease in the superficial femoral (SFA) and popliteal arteries by providing a unique combination of strength, flexibility and vessel coverage.
Use the right tool for the job. Today experts outline the best way to identify people most likely to develop common and devastating heart rhythm disorders.
› Verified 5 days ago
Dr. Jose Luis Lebron Velazquez, MD General Practice Medicare: Medicare Enrolled Practice Location: Calle Francisco G. Bruno #106 Oeste, Guayama, PR 00784 Phone: 787-553-3655 | |
Dr. Cristina Elizabeth Lorenzo Puesan, M.D. General Practice Medicare: Medicare Enrolled Practice Location: Ashford Ave. #128, Ashford Medical Plaza Suite 201, Guayama, PR 00978 Phone: 787-864-0400 | |
Alex Ramon Sola Alicea, General Practice Medicare: Medicare Enrolled Practice Location: Urb. La Hacienda Calle 53, Am 15, Guayama, PR 00784 Phone: 939-284-4902 | |
Juan Jose Rivera, General Practice Medicare: Accepting Medicare Assignments Practice Location: Hospital Episcopal Cristo Redentor, Guayama, PR 00785 Phone: 787-772-9109 | |
Dr. Ruben A Perez Ramirez, M,D General Practice Medicare: Medicare Enrolled Practice Location: Ave.pedro Albizu Campos, Urb. La Hacienda, Guayama, PR 00784 Phone: 787-864-4300 Fax: 787-864-1070 | |
Dr. Luis R Melendez Del Valle, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: Ave Los Veteranos, Guayama, PR 00785 Phone: 787-864-3494 | |
Dr. Marco Antonio Alfonso, MD General Practice Medicare: Medicare Enrolled Practice Location: Hospital Menonita Guayama, Av. Pedro Albizu Campos, Guayama, PR 00714 Phone: 787-866-6668 |